DOB on asthma scripts?
May 13, 2014
THE draft report of the post
market review of PBS medicines
used to treat asthma in children
included the idea of having
the patient date of birth on
prescriptions.
The report found that
stakeholders considered that fixed
dose combinations (FDC) were not
suitable for children less than five
years old, but that analyses had
shown a small proportion of those
under five had received a supply
of FDC.
Adding the patient date of birth
would enable the dispenser to
query the prescriber on the reasons
for prescribing medicines if it were
outside age recommendations, the
report said.
The report said with a broader
enhancement of prescribing and
dispensing software, this would
improve quality of use of medicines
in children.
Such an enhancement would
include alerts for prescribers when
they tried to prescribe outside
of the product information age
groups.
The report said while
stakeholders had noted anecdotal
reports of benefits from home
visiting programs conducted by
pharmacists, no published evidence
was available.
The draft contains a range of
options for consideration by the
Pharmaceutical Benefits Advisory
Committee (PBAC), which included
the possible reevaluation of the
value of fixed dose combinations
(FDC) treatments for asthma in
children.
To read more, CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 May 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 May 14
